A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, parallel controlled, multicenter clinical trial to compare the
efficacy and safety of LY09004 and EYLEA in the Treatment of Wet Age-related Macular
Degeneration（wAMD)